Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001283303-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 19, 2026 |
| Document Date | Feb 17, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
30,000
Total Value
$469,115.32
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer and GC | Common Stock | โ | Feb 17, 2026 | Exercise/Conversion | 10,000 | $19.08 | $190,800.00 | 115,211 | Direct | โ | View Details | |
Chief Legal Officer and GC | Common Stock | โ | Feb 17, 2026 | Sale | 5,679 | $27.50 | $156,195.22 | 109,532 | Direct | โ | View Details | |
Chief Legal Officer and GC | Common Stock | โ | Feb 17, 2026 | Sale | 4,321 | $28.26 | $122,120.10 | 105,211 | Direct | โ | View Details | |
Chief Legal Officer and GC | Employee stock option (right to buy) | Derivative | Feb 17, 2026 | Exercise/Conversion | 10,000 | $0.00 | $0.00 | 20,000 | Direct | โ | View Details |